Mechanisms for 2-methoxyestradiol-induced apoptosis of prostate cancer cells

被引:86
作者
Bu, SZ
Blaukat, A
Fu, X
Heldin, NE
Landström, M
机构
[1] Biomed Ctr, Ludwig Inst Canc Res, SE-75124 Uppsala, Sweden
[2] Uppsala Univ, Dept Womens & Childrens Hlth Obstet & Gynaecol, SE-75185 Uppsala, Sweden
[3] Uppsala Univ, Rudbeck Lab, Dept Genet & Pathol, SE-75185 Uppsala, Sweden
关键词
apoptosis; Bcl-2; breast cancer; 2-methoxyestradiol; prostate cancer; stress-activated protein kinase/c-Jun N-terminal kinase;
D O I
10.1016/S0014-5793(02)03478-6
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
Prostate and breast carcinomas are sex hormone-related carcinomas, which are known to be associated with an over-expression of the proto-oncogene Bel-2. Here, we report that 2-methoxyestradiol (2-ME), an endogenous metabolite of estrogen that does not bind to nuclear estrogen receptors, effectively induces apoptosis in Bcl-2-expressing human prostate and breast carcinoma cells in vitro and in a rat prostate tumor model in vivo. In several cell lines derived from prostate, breast, liver and colorectal carcinomas, 2-ME treatment led to an activation of c-Jun N-terminal kinase (JNK) and phosphorylation of Bcl-2, which preceded the induction of apoptosis. In summary, our data suggest that 2-ME induces apoptosis in epithelial carcinomas by causing phosphorylation of JNK, which appears to be correlated with phosphorylation of Bcl-2. (C) 2002 Federation of European Biochemical Societies. Published by Elsevier Science B.V. All rights reserved.
引用
收藏
页码:141 / 151
页数:11
相关论文
共 68 条
[1]
2-methoxyestradiol arrests cells in mitosis without depolymerizing tubulin [J].
Attalla, H ;
Makela, TP ;
Adlercreutz, H ;
Andersson, LC .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 228 (02) :467-473
[2]
2-methoxyestradiol-induced phosphorylation of Bcl-2:: Uncoupling from JNK/SAPK activation [J].
Attalla, H ;
Westberg, JA ;
Andersson, LC ;
Adlercreutz, H ;
Mäkelä, TP .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 247 (03) :616-619
[3]
Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance [J].
Boehm, T ;
Folkman, J ;
Browder, T ;
OReilly, MS .
NATURE, 1997, 390 (6658) :404-407
[4]
BRAWER MK, 1993, CANCER-AM CANCER SOC, V71, P899, DOI 10.1002/1097-0142(19930201)71:3+<899::AID-CNCR2820711406>3.0.CO
[5]
2-6
[6]
Mammalian MAP kinase signalling cascades [J].
Chang, LF ;
Karin, M .
NATURE, 2001, 410 (6824) :37-40
[7]
c-jun N-terminal kinase mediates apoptotic signaling induced by N-(4-hydroxyphenyl)retinamide [J].
Chen, YR ;
Zhou, GS ;
Tan, TH .
MOLECULAR PHARMACOLOGY, 1999, 56 (06) :1271-1279
[8]
Inhibition of the c-Jun N-terminal kinase (JNK) signaling pathway by curcumin [J].
Chen, YR ;
Tan, TH .
ONCOGENE, 1998, 17 (02) :173-178
[9]
COLOMBEL M, 1993, AM J PATHOL, V143, P390
[10]
Cory S, 1999, CANCER RES, V59, p1685S